Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN116554185B reveals a dual-catalytic route for chiral spiro oxindoles, offering high stereoselectivity and scalable manufacturing for pharmaceutical supply chains.
Novel electrochemical method for α-aminomethyl tetrazole. Reduces oxidants, simplifies purification. Reliable supply for pharmaceutical intermediates.
Patent CN110950793B details a metal-free, biphasic synthesis of chiral diarylindolemethanes with high stereoselectivity, offering cost-effective supply chain solutions.
Patent CN108299297A details a mild Ag2O-mediated radical cyclization for 6-alkylphenanthridines, offering high yields and broad substrate tolerance for efficient manufacturing.
Novel one-pot method for Edoxaban Tosylate intermediate ensures high purity and streamlined manufacturing. Reliable pharmaceutical intermediates supplier offering cost-effective solutions.
Novel synthesis route for Resmetirom intermediate offers high purity and scalable production for reliable pharmaceutical intermediate supply chains.
Novel double-protection strategy enhances purity and yield for idarubicin hydrochloride. Streamlined process offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel amide-type solanesol derivatives with antitumor activity. Efficient synthesis via mild coupling ensures high purity and cost-effective manufacturing for pharma applications.
Novel chlorination-coupling method for alpha nucleosides. Reduces purification steps, improves selectivity for antisense drug manufacturing.
Patent CN118852253B reveals metal-free visible light catalysis for high-purity heterocyclic compounds offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN109912531B details a novel purification method for Febuxostat intermediates, achieving 99.8% purity and significantly improved yields for cost-effective manufacturing.
Patent CN107245070B details a novel purification method reducing genotoxic impurities in Imatinib to below 2ppm with over 99.8% purity, offering significant cost and supply chain advantages.
Patent CN107033079A details a high-purity Eslicarbazepine Acetate method. Achieve cost reduction and supply chain reliability with scalable pharmaceutical manufacturing.
Advanced preparation method for penehyclidine impurities via epoxide ring-opening. Offers high purity, simplified processing, and reliable supply for pharmaceutical quality control.
Patent CN105646634A details novel impurity synthesis routes ensuring high purity pharmaceutical intermediates supply chain stability and cost efficiency for global buyers.
Patent CN1781915A reveals a high-yield, safe process for oxazolylethanol derivatives, replacing hazardous reagents with aqueous systems for cost-effective API manufacturing.
Patent CN1043646C details a high-yield d4T process avoiding hazardous reagents, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Advanced one-step process for high-purity dexamethasone sodium phosphate. Reduces production costs and enhances supply chain reliability for API manufacturing.
Novel copper-catalyzed synthesis offers high purity intermediates. Streamlined process reduces costs and enhances supply chain reliability for antitumor drug development.
Advanced patent-based synthesis of strontium ranelate ensures high purity and yield. Discover cost-effective manufacturing solutions for pharmaceutical intermediates supply chains.